Swipe to change view · pinch to zoom
Tirzepatide 15 mg lyophilized research peptide vial, PRIMEGEN LABS front label. Buy Tirzepatide 15 mg from PrimeGen Labs — 99.1% purity lyophilized Tirzepatide peptide for laboratory research, third party tested by HPLC and mass spectrometry, supplied in a sealed 10 mL borosilicate vial with a batch-matched certificate of analysis.
Dual GIP / GLP-1 agonist
Dual incretin receptor agonist studied for combined GIP and GLP-1 pathway activity in metabolic assays.
For laboratory research use only. Not for human or veterinary consumption.
Long-term
-20 °C, sealed, desiccated
In transit
Ambient stable up to 21 days
After reconstitution
2–8 °C, use within 21 days
Light exposure
Protect from direct light
Lot XX · HPLC + MS report issued by an independent laboratory. The released PDF is available on request.
Tirzepatide is a 39-residue synthetic peptide engineered from the GIP scaffold with sufficient GLP-1 receptor cross-reactivity to act as a dual incretin agonist. Its appearance in the literature reopened comparative questions about whether combined GIP and GLP-1 pathway engagement produces additive or distinct downstream signatures relative to single-receptor agonists.
Studies describe imbalanced dual agonism: higher intrinsic potency at the GIP receptor than at the GLP-1 receptor, with biased recruitment of beta-arrestin at the latter. Both receptors couple to Gs and raise cAMP, but the differing internalisation kinetics are a common focus of receptor-trafficking work.
Listed fields describe where this sequence appears in published in vitro and preclinical literature. They are not indications, applications, or claims of effect.
Fully soluble in sterile water and in bacteriostatic water. Swirl gently; the peptide is surface-active and will foam if shaken.
As a sealed lyophilized powder the material is stable for extended periods at -20 °C when kept desiccated and protected from light. Once in solution, stability shortens considerably: aqueous stocks are normally held at 2-8 °C for short term work or aliquoted and frozen for longer storage. Repeated freeze-thaw cycling is the most common cause of measurable potency loss.
Single sequence per vial, sealed under inert gas in USP Type I borosilicate glass with a butyl rubber stopper and crimped aluminium overseal. Each vial carries a printed PRIMEGEN LABS label with product name, strength, lot number, manufacture and retest dates, storage temperature and a QR code linking to the lot record. Vials ship in a rigid foam insert inside a protective mailer at ambient temperature.
Compare with similar compounds
| Compound | Strength | Category | Molecular weight | Availability | Price |
|---|---|---|---|---|---|
| TirzepatideThis page | 15 mg | Weight Management Research | 4813.45 g/mol | Low stock · few lots left | $122.00 |
| Semaglutide | 2 mg | Weight Management Research | 4113.58 g/mol | In stock | $23.00 |
| Retatrutide | 5 mg | Weight Management Research | ~4731 g/mol | Backorder · next lot, 5–7 business days | $60.00 |
| Cagrilintide | 5 mg | Weight Management Research | ~3750 g/mol | In stock | $85.00 |
Pairs well with
Complementary compounds researchers run alongside Tirzepatide — never competing alternatives.
Complete your order
Laboratory consumables matched to 1 vial in your cart.
Bacteriostatic Water
30 mL
1 × 30 mL — one vial of diluent per 3 peptide vials
Sterile Syringes
10-pack · 1 mL
10-pack covers a standard order
Alcohol Prep Pads
100-pack
Septum decontamination before every draw
Vial Storage Case
25 slots
Keeps lots organised and light-protected
Researchers also viewed
Weight Management Research
Strength
2 mg
Purity
99.3%
Weight Management Research
Strength
5 mg
Purity
99.0%
Weight Management Research
Strength
5 mg
Purity
99.2%
Tirzepatide · 15 mg
Low stock · few lots left